InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,349.67
(
0.16%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gr8db8

Send PM Follow Ignore
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

gr8db8

Re: trading_cyclist post# 55534

Sunday, 10/26/2014 11:50:34 PM

Sunday, October 26, 2014 11:50:34 PM

Post# of 80490
@trading_cyclist are you talking about combo drugs like Lirilumab/Nivolumab (http://clinicaltrials.gov/show/NCT01714739)? Not that common, imo.

Most patients will take additional meds to reduce side effects like nausea, diarrhea, rashes, etc ... but I don't think you're talking about that, right?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up